Recruiting Patients for Phase 1 Trial of the X-PACT System in Certain Solid Tumors

Immunolight LLC, a clinical stage biopharmaceutical firm leading the way in advancing technologies to transform cancer treatment, announced today it is now recruiting patients for a Phase 1 study of its X-PACT Cancer Treatment system in advanced solid cancer tumors.